14 institutions reported holding $348,699 of CNS PHARMACEUTICALS INC (CNSP) in SEC 13F filings for 2026-03-31. Largest institutional holders: Stonepine Capital Management, LLC ($145,790), Ikarian Capital, LLC ($109,992), GEODE CAPITAL MANAGEMENT, LLC ($55,653), BOOTHBAY FUND MANAGEMENT, LLC ($32,322), Tower Research Capital LLC (TRC) ($3,131). Source: SEC Form 13F.
| Rank | Institution | Value | Shares | Change |
|---|---|---|---|---|
| 1 | Stonepine Capital Management, LLC | $145,790 | 61,000 | Added |
| 2 | Ikarian Capital, LLC | $109,992 | 45,830 | Hold |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | $55,653 | 23,189 | New |
| 4 | BOOTHBAY FUND MANAGEMENT, LLC | $32,322 | 13,524 | Hold |
| 5 | Tower Research Capital LLC (TRC) | $3,131 | 1,310 | New |
| 6 | UBS Group AG | $1,742 | 729 | Added |
| 7 | Sound Income Strategies, LLC | $36 | 16 | Hold |
| 8 | BARRETT & COMPANY, INC. | $19 | 8 | Hold |
| 9 | MAI Capital Management | $8 | 3 | Hold |
| 10 | CITIGROUP INC | $2 | 1 | New |
| 11 | DANSKE BANK A/S | $2 | 1 | Hold |
| 12 | Caitong International Asset Management Co., Ltd | $2 | 1 | New |
| 13 | DRW Securities, LLC | $0 | 0 | Exited |
| 14 | BANK OF AMERICA CORP /DE/ | $0 | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31